Triple Therapy-Based on Tegoprazan, a New Potassium-Competitive Acid Blocker, for First-Line Treatment of Helicobacter pylori Infection: A Randomized, Double-Blind, Phase III, Clinical Trial
Authors:
- Yoon Jin ChoiYCYoon Jin Choi
- Yong Chan LeeYLYong Chan Lee
- Jung Mogg KimJung Mogg Kim
- Jin Il KimJKJin Il Kim
- Jeong Seop MoonJMJeong Seop Moon
- Yun Jeong LimYLYun Jeong Lim
- Gwang Ho BaikGBGwang Ho Baik
- Byoung Kwan SonBSByoung Kwan Son
- Hang Lak LeeHLHang Lak Lee
- Kyoung Oh KimKKKyoung Oh Kim
- Nayoung KimNKNayoung Kim
- Kwang Hyun KoKKKwang Hyun Ko
Top Cited Papers
Open Access
- 6 July 2022
- journal article
- research article
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 16 (4) , 535-546
Abstract
Yoon Jin Choi, Yong Chan Lee, Jung Mogg Kim, Jin Il Kim, Jeong Seop Moon, Yun Jeong Lim, Gwang Ho Baik, Byoung Kwan Son, Hang Lak Lee, Kyoung Oh Kim, Nayoung Kim, Kwang Hyun Ko, Hye-Kyung Jung, Ki-Nam Shim, Hoon Jai Chun, Byung-Wook Kim, Hyuk Lee, Jie-Hyun Kim, Hyunsoo Chung, Sang Gyun Kim, and Jae Young Jang. Gut and Liver 2022;16:535-46. https://doi.org/10.5009/gnl220055Keywords
Funding Information
- HK inno.N Corp.
This publication has 25 references indexed in Scilit:
- Antimicrobial susceptibility of 6 antimicrobial agents in Helicobacter pylori clinical isolates by using EUCAST breakpoints compared with previously used breakpointsEnfermedades Infecciosas y Microbiología Clínica, 2017
- Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind studyGut, 2016
- Review article: the global emergence ofHelicobacter pyloriantibiotic resistanceAlimentary Pharmacology & Therapeutics, 2015
- The First-in-Class Potassium-Competitive Acid Blocker, Vonoprazan Fumarate: Pharmacokinetic and Pharmacodynamic ConsiderationsClinical Pharmacokinetics, 2015
- Kyoto global consensus report onHelicobacter pylorigastritisGut, 2015
- Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised editionJournal of Gastroenterology and Hepatology, 2014
- Comparative study of esomeprazole and lansoprazole in triple therapy for eradication ofHelicobacter pyloriin JapanWorld Journal of Gastroenterology, 2014
- Regional Difference of Antibiotic Resistance ofHelicobacter pyloriStrains in KoreaThe Korean Journal of Gastroenterology, 2011
- Helicobacter pyloriInfection and the Development of Gastric CancerNew England Journal of Medicine, 2001
- UNIDENTIFIED CURVED BACILLI ON GASTRIC EPITHELIUM IN ACTIVE CHRONIC GASTRITISThe Lancet, 1983